Epidemiology and clinical characteristics of Henoch-Schönlein purpura associated with Mycoplasma pneumoniae infection in 131 children in Hubei province, China
Main Article Content
Keywords
Downloads
Download data is not yet available.
Abstract 791
PDF Downloads 249
HTML Downloads 123
References
Wang JJ, Xu Y, Liu FF, et al. Association of the infectious triggers with childhood Henoch-Schonlein purpura in Anhui province, China. J Infect Public Health. 2020;13(1):110-117.
https://doi.org/10.1016/j.jiph.2019.07.004
PMid:31337540
2. Wang X, Zhu Y, Gao L, Wei S, Zhen Y, Ma Q. Henoch-Schonlein purpura with joint involvement: Analysis of 71 cases. Pediatr Rheumatol Online J. 2016;14(1):20.
https://doi.org/10.1186/s12969-016-0080-x
PMid:27029321 PMCid:PMC4815193
3. Chen JY, Mao JH. Henoch-Schonlein purpura nephritis in children: incidence, pathogenesis and management. World J Pediatr. 2015;11(1):29-34.
https://doi.org/10.1007/s12519-014-0534-5
PMid:25557596
4. Hetland LE, Susrud KS, Lindahl KH, Bygum A. Henoch-Schonlein Purpura: A Literature Review. Acta Derm Venereol. 2017;97(10):1160-1166.
https://doi.org/10.2340/00015555-2733
PMid:28654132
5. Gao LW, Yin J, Hu YH, et al. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016. Epidemiol Infect. 2019;147: e192.
https://doi.org/10.1017/S0950268819000839
PMid:31364532 PMCid:PMC6518602
6. Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010; 69 (5):798-806.
https://doi.org/10.1136/ard.2009.116657
PMid:20413568
7. Hu YM, Jiang ZF. Zhu Futang's Practical Pediatrics. 7th Ed., China, People's Medical Publishing House. 2002;1175-1180.
8. Respiratory Branch of Chinese Pediatric Society of Chinese Medical Association. Expert consensus on diagnosis and treatment of Mycoplasma
pneumoniae pneumonia in children. Chinese Journal of Applied Clinical Pediatrics. 2015;17: 1304 -1308.
9. Timitilli A, Di Rocco M, Nattero G, Tacchella A, Giacchino R. Unusual manifestations of infections due to Mycoplasma pneumoniae in children. Infez Med. 2004;12(2):113-117.
10. Wang Y, Zhang Y, Lu W, Wang L. Serum Tumor Necrosis Factor- α and Interferon- γ Levels in Pediatric Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis. Can Respir J. 2018; 2018:8354892.
https://doi.org/10.1155/2018/8354892
PMid:30275916 PMCid:PMC6151362
11. Kuźma-Mroczkowska E, Pańczyk-Tomaszewska M, Szmigielska A, Szymanik-Grzelak H, Roszkowska-Blaim M. Mycoplasma pneumoniae as a trigger for Henoch-Schonlein purpura in children. Cent Eur J Immunol. 2015;40(4):489-492.
https://doi.org/10.5114/ceji.2015.56976
PMid:26862316 PMCid:PMC4737748
12. Yiallouros P, Moustaki M, Voutsioti A, Sharifi F, Karpathios T. Association of Mycoplasma pneumoniae infection with Henoch-Schonlein purpura. Prague Med Rep. 2013;114(3):177-179.
https://doi.org/10.14712/23362936.2014.20
PMid:24093818
13. Lim CS, Lim SL. Henoch-Schönlein purpura associated with Mycoplasma pneumoniae infection. Cutis, 2011;87(6):273-276.
14. Rhim JW, Kang HM, Han JW, Lee KY. A Presumed Etiology of Kawasaki Disease Based on Epidemiological Comparison with Infectious or Immune-Mediated Diseases. Front Pediatr. 2019; 7:202.
https://doi.org/10.3389/fped.2019.00202
PMid:31165053 PMCid:PMC6536658
15. Siomou E, Kollios KD, Papadimitriou P, Kostoula A, Papadopoulou ZL. Acute nephritis and respiratory tract infection caused by Mycoplasma pneumoniae: case report and review of the literature. Pediatr Infect Dis J. 2003;22(12):1103-1106.
https://doi.org/10.1097/01.inf.0000104531.58503.90
PMid:14688577
https://doi.org/10.1016/j.jiph.2019.07.004
PMid:31337540
2. Wang X, Zhu Y, Gao L, Wei S, Zhen Y, Ma Q. Henoch-Schonlein purpura with joint involvement: Analysis of 71 cases. Pediatr Rheumatol Online J. 2016;14(1):20.
https://doi.org/10.1186/s12969-016-0080-x
PMid:27029321 PMCid:PMC4815193
3. Chen JY, Mao JH. Henoch-Schonlein purpura nephritis in children: incidence, pathogenesis and management. World J Pediatr. 2015;11(1):29-34.
https://doi.org/10.1007/s12519-014-0534-5
PMid:25557596
4. Hetland LE, Susrud KS, Lindahl KH, Bygum A. Henoch-Schonlein Purpura: A Literature Review. Acta Derm Venereol. 2017;97(10):1160-1166.
https://doi.org/10.2340/00015555-2733
PMid:28654132
5. Gao LW, Yin J, Hu YH, et al. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016. Epidemiol Infect. 2019;147: e192.
https://doi.org/10.1017/S0950268819000839
PMid:31364532 PMCid:PMC6518602
6. Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010; 69 (5):798-806.
https://doi.org/10.1136/ard.2009.116657
PMid:20413568
7. Hu YM, Jiang ZF. Zhu Futang's Practical Pediatrics. 7th Ed., China, People's Medical Publishing House. 2002;1175-1180.
8. Respiratory Branch of Chinese Pediatric Society of Chinese Medical Association. Expert consensus on diagnosis and treatment of Mycoplasma
pneumoniae pneumonia in children. Chinese Journal of Applied Clinical Pediatrics. 2015;17: 1304 -1308.
9. Timitilli A, Di Rocco M, Nattero G, Tacchella A, Giacchino R. Unusual manifestations of infections due to Mycoplasma pneumoniae in children. Infez Med. 2004;12(2):113-117.
10. Wang Y, Zhang Y, Lu W, Wang L. Serum Tumor Necrosis Factor- α and Interferon- γ Levels in Pediatric Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis. Can Respir J. 2018; 2018:8354892.
https://doi.org/10.1155/2018/8354892
PMid:30275916 PMCid:PMC6151362
11. Kuźma-Mroczkowska E, Pańczyk-Tomaszewska M, Szmigielska A, Szymanik-Grzelak H, Roszkowska-Blaim M. Mycoplasma pneumoniae as a trigger for Henoch-Schonlein purpura in children. Cent Eur J Immunol. 2015;40(4):489-492.
https://doi.org/10.5114/ceji.2015.56976
PMid:26862316 PMCid:PMC4737748
12. Yiallouros P, Moustaki M, Voutsioti A, Sharifi F, Karpathios T. Association of Mycoplasma pneumoniae infection with Henoch-Schonlein purpura. Prague Med Rep. 2013;114(3):177-179.
https://doi.org/10.14712/23362936.2014.20
PMid:24093818
13. Lim CS, Lim SL. Henoch-Schönlein purpura associated with Mycoplasma pneumoniae infection. Cutis, 2011;87(6):273-276.
14. Rhim JW, Kang HM, Han JW, Lee KY. A Presumed Etiology of Kawasaki Disease Based on Epidemiological Comparison with Infectious or Immune-Mediated Diseases. Front Pediatr. 2019; 7:202.
https://doi.org/10.3389/fped.2019.00202
PMid:31165053 PMCid:PMC6536658
15. Siomou E, Kollios KD, Papadimitriou P, Kostoula A, Papadopoulou ZL. Acute nephritis and respiratory tract infection caused by Mycoplasma pneumoniae: case report and review of the literature. Pediatr Infect Dis J. 2003;22(12):1103-1106.
https://doi.org/10.1097/01.inf.0000104531.58503.90
PMid:14688577
Article Sidebar
Published
Apr 29, 2021
Article Details
How to Cite
Hu, hongbo (2021) “Epidemiology and clinical characteristics of Henoch-Schönlein purpura associated with Mycoplasma pneumoniae infection in 131 children in Hubei province, China”, Mediterranean Journal of Hematology and Infectious Diseases, 13(1), p. Page e2021037. doi: 10.4084/MJHID.2021.037.
Issue
Section
Scientific Letters
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.